Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Jul 9:2015:bcr2015210189.
doi: 10.1136/bcr-2015-210189.

Sarcoidosis-related hypercalcaemia due to production of parathyroid hormone-related peptide

Affiliations
Case Reports

Sarcoidosis-related hypercalcaemia due to production of parathyroid hormone-related peptide

Daniel H van Raalte et al. BMJ Case Rep. .

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] BMJ Case Rep. 2015 Sep 14;2015:bcr2015210189corr1. doi: 10.1136/bcr-2015-210189corr1. BMJ Case Rep. 2015. PMID: 26370637 Free PMC article. No abstract available.

Abstract

Hypercalcaemia is frequently observed in patients with sarcoidosis. This is classically attributed to ectopic production of 1,25 dihydroxy vitamin D by sarcoid granulomas. We present a case of sarcoidosis-related hypercalcaemia with normal vitamin D levels. In this patient, production of parathyroid hormone-related peptide (PTHrp) was the cause for sarcoidosis-induced hypercalcaemia. As such, plasma PTHrp levels were increased and bone marrow granulomas stained positively for PTHrp expression. Medium-dose prednisolone treatment improved symptoms of sarcoidosis and normalised serum calcium, and PTHrp concentrations. Thus, production of PTHrp may be the cause for hypercalcaemia in some patients with sarcoidosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Bone marrow biopsy shows the presence of a non-caseating granuloma (arrow) (H&E stain). (B) Parathyroid hormone-related peptide (PTHrp) immunohistochemistry demonstrating PTHrp expression by the granuloma.

References

    1. Baughman RP, Teirstein AS, Judson MA et al. . Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164:1885–9. 10.1164/ajrccm.164.10.2104046 - DOI - PubMed
    1. Adams JS, Singer FR, Gacad MA et al. . Isolation and structural identification of 1,25-dihydroxyvitamin D3 produced by cultured alveolar macrophages in sarcoidosis. J Clin Endocrinol Metab 1985;60:960–6. 10.1210/jcem-60-5-960 - DOI - PubMed
    1. Krikorian A, Shah S, Wasman J. Parathyroid hormone-related protein: an unusual mechanism for hypercalcemia in sarcoidosis. Endocr Pract 2011;17:e84–6. 10.4158/EP11060.CR - DOI - PubMed
    1. Wysolmerski JJ. Parathyroid hormone-related protein: an update. J Clin Endocrinol Metab 2012;97:2947–56. 10.1210/jc.2012-2142 - DOI - PMC - PubMed
    1. Horwitz MJ, Tedesco MB, Sereika SM et al. . Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab 2003;88:1603–9. 10.1210/jc.2002-020773 - DOI - PubMed

Publication types